在患有莱维体痴呆症的痴呆症中,血脑屏障崩
Jinghuan Gan1, Ziming Xu2, Zhichao Chen1
1Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Fluids and barriers of the CNS
|September 17, 2024
概括
血脑屏障 (BBB) 泄漏在患有莱维体 (DLB) 的痴呆症中比阿尔茨海默病 (AD) 更严重. 这种BBB功能障碍与DLB患者的痴呆症严重程度和血氨基酸β水平相关.
科学领域:
- 神经科学是一个神经科学.
- 放射学 放射学是一门学科.
- 神经学 神经学
背景情况:
- 血脑屏障 (BBB) 功能障碍与阿尔茨海默氏症 (AD) 等神经退行性疾病有关.
- 在勒维体痴呆症 (DLB) 中,BBB功能障碍的作用仍未得到充分研究.
- 这项研究研究了BBB在DLB中的透性及其与血氨基酸β (Aβ) 的关联.
研究的目的:
- 与阿尔茨海默病 (AD) 和健康对照组 (HC) 相比,评估患有勒维体痴呆症 (DLB) 的患者的血脑屏障 (BBB) 透性.
- 确定DLB.在BBB透性和血氨基酸β (Aβ) 水平之间的关联.
- 在研究的队列中探索BBB透性和痴呆症严重程度之间的关系.
主要方法:
- 这是一项前性研究,涉及24名健康对照 (HC),29名AD患者和20名DLB患者.
- 动态对比增强磁共振成像 (DCE-MRI) 用于评估BBB透性 (Ktrans).
- 斯皮尔曼相关性和多变量线性回归分析了Ktrans,临床特征和血Aβ水平之间的关联.
主要成果:
- 与HC相比,DLB患者在大脑皮层,头顶和叶中表现出明显更高的BBB透性 (Ktrans).
- 与AD相比,BBB透性在DLB中显著增加,在大脑皮层和尾叶.
- 在DLB患者中,增加的Ktrans值与更高的临床痴呆评分分数和较高的血Aβ1-42/Aβ1-40比率相关.
结论:
- 血脑屏障 (BBB) 泄漏是莱维体痴呆症 (DLB) 的常见特征,在特定的大脑区域可能比阿尔茨海默病 (AD) 更严重.
- 在DLB中,BBB泄漏与痴呆症的严重程度和血氨基酸β (Aβ) 水平有关.
- 这些发现凸显了BBB功能障碍是DLB病原和进展的关键因素.
相关概念视频
The Blood-brain Barrier
47.0K
Overview
47.0K
Dementia
102
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
102
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K
Alzheimer's Disease: Overview
451
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
451


